Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07425587Not Yet Recruiting

Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study

Role: lead

NCT06654895Recruiting

Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study

Role: lead

NCT06181604Completed

Multicenter Symphony IL-6 Monitoring Sepsis ICU Study

Role: lead

NCT05665153Unknown

Symphony IL-6 Study in Patients at Risk of Severe Sepsis

Role: lead

NCT05060250Unknown

Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis Due to COVID-19

Role: lead

NCT05048927Unknown

Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe Sepsis

Role: lead

NCT05048888Unknown

Symphony IL-6 Reference Range Study

Role: lead

All 7 trials loaded